Price: quote on request. Your total cost is quoted in writing per case.
We reply within one business dayGet my quote

Sickle cell disease (SCD): US-approved treatments and how Gulf families can access them

Creator: Reserve Meds
Published: 2026-10-17

A plain guide for families in the Gulf, checked against US FDA labels, Gulf drug registers and published medical research.

Reviewed by the Reserve Meds clinical operations team on 17 October 2026.

Sickle cell disease: the short answer

The US FDA has approved three medicines on this page for sickle cell disease, each for specific patients. Two of them are on at least one Gulf register we checked, so ask your hospital about local supply first. Otherwise the hospital can request a named-patient import. Reserve Meds is a digital health company. We do not diagnose or prescribe.

US FDA-approved medicines on this page: Casgevy, Lyfgenia and Endari.
Gulf registration (checked 17 October 2026): see each medicine below.
Legal route: Local supply where listed; otherwise a named-patient import request filed by the treating hospital; cell and gene therapies at a qualified center.
Price: Quote on request.

What is sickle cell disease?

Sickle cell disease (SCD) is a group of inherited red blood cell disorders. The hemoglobin forms stiff rods that change red blood cells into a crescent or sickle shape. Sickle cells burst easily and last only 10 to 20 days instead of 90 to 120, which causes anemia.^[1]

Sickle cells can also block blood vessels, causing sudden severe pain called pain crises and damage to organs such as the lungs, kidneys, spleen and brain. Signs usually begin in early childhood and include anemia, repeated infections and episodes of pain. People with SCD are born with two sickle cell genes, one from each parent.^{[1, 2]}

Some treatments address symptoms, while others address the genetic cause. In the US, two gene therapies are approved for patients with repeated vaso-occlusive crises, and an oral amino acid is approved to reduce acute complications.^{[2, 3, 4, 5]}

Sickle cell disease in the Gulf

A systematic review of 98 studies from the Gulf Cooperation Council countries found that the prevalence of SCD ranged from 0.24% to 5.8%, and sickle cell trait from 1.02% to 45.8%. Consanguineous marriage was identified as a risk factor.^[6]

US FDA-approved medicines for sickle cell disease

Each medicine below is approved in the US for a specific group of patients. The wording summarizes the current US label. Your specialist decides whether any of them is right for the patient.

Casgevy (exagamglogene autotemcel)
FDA-approved for patients 2 years and older with sickle cell disease and recurrent vaso-occlusive crises, and transfusion-dependent beta thalassemia. It is a one-time gene-edited therapy made from the patient's own blood stem cells, given at a qualified center.^[3]
Given at a qualified treatment center. Gulf registers: Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, India, Pakistan
Lyfgenia (lovotibeglogene autotemcel)
FDA-approved for patients 12 years and older with sickle cell disease and a history of vaso-occlusive events. It is a one-time gene therapy made from the patient's own blood stem cells, given at a qualified center.^[4]
Given at a qualified treatment center. Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: not found by brand name in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt, Jordan, Iraq, India, Pakistan
Endari (glutamine)
FDA-approved for reducing acute complications of sickle cell disease in adults and children 5 years and older. It is an oral powder (L-glutamine) mixed with food or drink.^[5]
Gulf registers: Saudi Arabia: not found by brand name in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register.^{[7, 8]}
Country guides: Saudi Arabia, UAE, Kuwait, Qatar, Bahrain, Oman, Egypt

How families in the Gulf can access these medicines

If the medicine is listed in your country. Ask your specialist and the hospital pharmacy about local supply first. A listing does not mean every hospital stocks the medicine, and another brand of the same medicine may also be registered, but local supply is usually the fastest route and you may not need us.

If it is not registered. The usual legal route is a named-patient request: the treating hospital, on your specialist's written request, asks the national regulator for permission to import the medicine for one patient, using the US FDA approval as the reference. In Saudi Arabia the SFDA Special Access Program guidance covers these requests; in Bahrain, NHRA Circular 41 of 2020 sets the procedure. Other Gulf countries have their own procedures, which the hospital pharmacy confirms.^{[9, 10]} Once approval is in place, Reserve Meds arranges supply through a US-licensed pharmaceutical wholesale partner to the hospital pharmacy.

For Casgevy and Lyfgenia. These treatments are made for each patient or need a specialized procedure, so treatment happens at a qualified center. For most Gulf families that means a referral from the treating specialist to a center that can give the treatment. A local hospital can only give it if the manufacturer agrees to supply that hospital and the regulator approves. We cannot promise that a manufacturer will agree.

Who does what

Your treating specialist decides whether a medicine is right for the patient and writes the letter.
The hospital checks local supply, files any import request, and gives the treatment safely.
The national regulator decides whether to approve the import of a medicine that is not registered.
The manufacturer decides where its medicine can be supplied, especially for cell and gene therapies.
Reserve Meds helps organize records, coordinates US supply through our wholesale partner, shipping and updates to your family. We do not give medical advice.

Documents you will usually need

A letter from the treating specialist with the diagnosis, past treatments and why the medicine is being considered
Reports that confirm the diagnosis, such as laboratory, genetic, imaging or pathology results, translated into English where needed
Recent clinic notes and a list of current medicines
For a hospital import request: the prescription, the hospital's request form and the written consent of the patient or guardian
Proof of the US FDA approval and the US prescribing information (we can supply these)

We give you a written timeline estimate once we see the hospital file. The regulator, the treatment center and the manufacturer set their own timelines.

What treatment costs

Quote on request. Your total cost depends on the medicine, the dose, shipping, import steps and coordination. Your coordination fee is quoted in writing for your case before you commit. No hidden charges.

How Reserve Meds helps

Reserve Meds is a digital health company. Medicines are supplied through a US-licensed pharmaceutical wholesale partner. We help your doctor and hospital prepare the file, arrange US supply and temperature-controlled shipping once approval is in place, and keep your family updated. We coordinate access to FDA-approved medicines only. Investigational medicines are only available through a manufacturer's expanded-access program requested by the treating physician; we can explain that route, but we do not supply them.

Ask us about treatment for sickle cell disease

Tell us the medicine, your country and a WhatsApp or phone number. We reply within one business day. On WhatsApp we usually reply the same day.

Frequently asked questions

Is there an FDA-approved treatment for sickle cell disease?

Yes. The medicines on this page have US FDA approval for specific groups of patients: Casgevy, Lyfgenia and Endari. The exact conditions are in each US label and are summarized above. Your specialist decides whether any of them fits.

Is Casgevy available in Saudi Arabia or the UAE?

Saudi Arabia: listed in the SFDA drugs list. Abu Dhabi: has an active code in the Abu Dhabi DoH drug code list. Checked 17 October 2026. UAE federal status, Kuwait, Qatar, Bahrain and Oman: not verified in a public register. A listing in Abu Dhabi does not show federal UAE status.

How can a family in the Gulf get Casgevy?

It is given at a qualified center. Your specialist refers the patient, the center checks eligibility, and the family plans funding and travel. A local hospital can only give it if the manufacturer agrees to supply it and the regulator approves.

How much does treatment cost?

Quote on request. Your total cost, including the medicine, shipping, import steps and coordination, is quoted in writing for your case before you commit. No hidden charges.

Is Casgevy available in the Gulf?

Check the register line under Casgevy above. We also publish detailed Casgevy country guides, linked from the medicine card, with the latest sourced status for each country.

Is sickle cell trait the same as sickle cell disease?

No. MedlinePlus explains that people with sickle cell disease are born with two sickle cell genes, one from each parent, while a person born with one sickle cell gene has sickle cell trait.

Sources for the last two answers: ^[3] ^[1]

Sources

Checked on 17 October 2026. Labels, registers and regulator rules change. Your hospital pharmacy confirms the current position before filing.

Sickle cell disease by country

This page is general health information, not medical advice. It does not replace a consultation with your doctor.